CXCL10 and tuberculosis: These results substantiated previous observations that the reduction of plasma IP-10 is associated with successful TB treatment (Azzurri et al., 2005; Djoba Siawaya et al., 2009); hence IP-10 could be utilized as a valuable indicator of clinical response and treatment success.